B. Barrow

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

M R Stearne, S L Palmer, M S Hammersley et al. · 1998 · 4.8K citations

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39

M R Stearne, S L Palmer, M S Hammersley et al. · 1998 · 1.4K citations

Hypertension, Pharmacotherapy, Blood Pressure +16

Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40

M R Stearne, S L Palmer, M S Hammersley et al. · 1998 · 303 citations

Hypertension, Cost Effectiveness Ratios, Cost Effectiveness Analysis +19

Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM

Jonathan Rachman, B. Barrow, J Lévy et al. · Diabetologia · 1997 · 268 citations · Full text

Metabolic Syndrome, Insulin Management, Diabetes +10

Normalization of Insulin Responses to Glucose by Overnight Infusion of Glucagon-Like Peptide 1 (7–36) Amide in Patients With NIDDM

Jonathan Rachman, Fiona M. Gribble, B. Barrow et al. · Diabetes · 1996 · 116 citations